drugset / Trial / NCT01244503

Prediction of Severity of Liver Disease by a 13C Octanoate Breath Test (OBT)

NCT01244503 ↗

NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of the study is to demonstrate that the ¹³C-Octanoate Breath Test (OBT) can be used as an aid, in conjunction with other clinical information and medical history, for evaluating disease severity and detecting NASH with a high probability.

Timeline

Start
2011-02
Primary completion
2012-05
Completion
2012-06

Outcome

Outcome not reported

Stopped: “Budgetary Issues”

Drugs

EvaluationDrugModalityDoseRoute
Subject SODIUM CAPRYLATE Small molecule 100 mg Oral